Alphabet Inc.’s Google and Apple Inc. announced a new system that will enable public health authorities to use smartphones to assist in contact tracing without having to build an app.

North Dakota, Wyoming and Alabama are the latest U.S. states launching apps to warn users about potential exposure to the novel coronavirus by tracking their encounters, representatives for the states told Reuters.

Virginia launched the first contact tracing app for the novel coronavirus in the United States that uses new technology from Apple Inc. and Alphabet Inc.’s Google.

As the 2020 presidential election looms, debate about the price of prescription drugs and healthcare will intensify; healthcare communication leaders share their thoughts on how their pharma clients can be a constructive part of the conversations.

China reported the country’s fewest new coronavirus infections since January and the lowest daily death toll for a week, but the World Health Organization said data suggesting the outbreak had slowed should still be viewed with caution.

Apple Inc. launched an app that will let users of the company’s devices to enroll in three health studies, allowing them to share health-related data for medical research.

Drugmaker Eli Lilly and Company said early results from a study suggest that Apple Inc. devices, including the iPhone, in combination with digital apps could differentiate people with mild Alzheimer’s disease dementia and those without symptoms.

Janssen Pharmaceutical and Apple have teamed up to determine if a new app for the Apple Watch – which has a built-in electrocardiogram – can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating complications.

Med Ad News spoke with Gene Fitzpatrick, senior VP of engagement strategy for Ogilvy CommonHealth Worldwide, about the future of augmented and virtual reality in healthcare marketing.

Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.